Jeffrey A Smisek insider trades: Finch Therapeutics Group (FNCH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 28, 2024 | FNCH | ↓ Sell | 6,642 | $2.57 | $17K | Direct | Mar 29, 2024 (1d) |
| Mar 28, 2024 | FNCH | ↓ Sell | 1,600 | $2.61 | $4K | By spouse | Mar 29, 2024 (1d) |
| Nov 22, 2023 | FNCH | ↓ Sell | 1,470 | $3.64 | $5K | Direct | Nov 27, 2023 (5d) |
| Mar 23, 2021 | FNCH | ↑ Buy | 88,235 | $17.00 | $1.5M | Indirect | Mar 25, 2021 (2d) |
| Apr 28, 2014 | UAL | ↑ Buy | 20,000 | $39.62 | $792K | Direct | Apr 28, 2014 (0d) |
| Aug 27, 2013 | UAL | ↑ Buy | 9,054 | $27.66 | $250K | Direct | Aug 27, 2013 (0d) |
| Mar 14, 2013 | NOV | ↓ Sell | 1,674 | $68.82 | $115K | Direct | Mar 15, 2013 (1d) |
| Aug 9, 2012 | UAL | ↑ Buy | 55,600 | $18.00 | $1.0M | Direct | Aug 13, 2012 (4d) |
| Nov 22, 2011 | UAL | ↑ Buy | 4,000 | $16.27 | $65K | Direct | Nov 23, 2011 (1d) |
| Aug 26, 2011 | UAL | ↑ Buy | 4,000 | $17.05 | $68K | Direct | Aug 29, 2011 (3d) |
| Aug 24, 2011 | UAL | ↑ Buy | 5,000 | $17.24 | $86K | Direct | Aug 25, 2011 (1d) |
| Aug 9, 2011 | UAL | ↑ Buy | 10,000 | $17.36 | $174K | Direct | Aug 10, 2011 (1d) |
| Nov 21, 2008 | NOV | ↑ Buy | 2,500 | $18.94 | $47K | Direct | Nov 21, 2008 (0d) |
| Nov 20, 2008 | NOV | ↑ Buy | 2,500 | $19.31 | $48K | Direct | Nov 21, 2008 (1d) |
| May 29, 2008 | NOV | ↑ Buy | 110 | $80.80 | $9K | Direct | Jun 2, 2008 (4d) |
| Apr 30, 2007 | NOV | ↓ Sell | 6,839 | $85.65 | $586K | Direct | Apr 30, 2007 (0d) |
| Oct 20, 2006 | CAL | ↓ Sell | 143,042 | $33.21 | $4.7M | Direct | Oct 23, 2006 (3d) |
| Oct 20, 2006 | CAL | ↓ Sell | 115,411 | $33.83 | $3.9M | Direct | Oct 23, 2006 (3d) |
| Oct 20, 2006 | CAL | ↓ Sell | 8,046 | $34.19 | $275K | Direct | Oct 23, 2006 (3d) |
| Apr 24, 2006 | CAL | ↓ Sell | 50,000 | $25.90 | $1.3M | Direct | Apr 25, 2006 (1d) |
| Sep 1, 2005 | NOV | ↓ Sell | 20,905 | $65.49 | $1.4M | Direct | Sep 2, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jeffrey A Smisek's insider trades
Jeffrey A Smisek is an insider at Finch Therapeutics Group (FNCH). Since Sep 1, 2005, Jeffrey has reported 11 open-market purchases worth $4.0M and 10 sales worth $12.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (19 filings), shares withheld for taxes (9 filings), option exercises (7 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FNCH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.